Concepedia

Avery Feit

AF

9

Publications

424

Citations

9

H-Index

2020

Active since

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Broad Institute

Dana-Farber Brigham Cancer Center

Avery Feit is an author at Harvard University specializing in genomics, chromatin, and bioinformatics.

ORCID

Top concepts

Publications per year

2020–2024

9

Publications

9

MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets

Xintao Qiu, Nadia Boufaied, Tarek Hallal et al. · Nature Communications · 2022 · 139 citations · Full text

Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition

Anne Fassl, Christopher T. Brain, Monther Abu-Remaileh et al. · Science Advances · 2020 · 100 citations · Full text

Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress

Yiji Liao, Chen-Hao Chen, Tengfei Xiao et al. · Proceedings of the National Academy of Sciences · 2022 · 51 citations · Full text

CoBRA: Containerized Bioinformatics Workflow for Reproducible ChIP/ATAC-Seq Analysis

Xintao Qiu, Avery Feit, Ariel Feiglin et al. · Genomics Proteomics & Bioinformatics · 2021 · 38 citations · Full text

, , +19

Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor–positive Breast Cancer

Cristina Guarducci, Agostina Nardone, Douglas Russo et al. · Clinical Cancer Research · 2024 · 31 citations · Full text

Rows per page

1–5 of 9